SHINE Medical Technologies, Inc., 52579 [2013-20622]

Download as PDF Federal Register / Vol. 78, No. 164 / Friday, August 23, 2013 / Notices BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket No. 50–608; NRC–2013–0053] SHINE Medical Technologies, Inc. Nuclear Regulatory Commission. ACTION: Notice of receipt and availability. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) staff acknowledges receipt of the second and final part of a two-part application for a construction permit, submitted by SHINE Medical Technologies, Inc. (SHINE). ADDRESSES: Please refer to Docket ID NRC–2013–0053 when contacting the NRC about the availability of information regarding this document. You may access publicly-available information related to this action by the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2013–0053. Address questions about NRC dockets to Carol Gallagher; telephone: 301–287–3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may access publicly available documents online in the NRC Library at https://www.nrc.gov/readingrm/adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced in this document (if that document is available in ADAMS) is provided the first time that the document is referenced. The application is available in ADAMS under Accession No. ML13172A324. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Steven Lynch, Office of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC, 20555– 0001; telephone: 301–415–1524; email: Steven.Lynch@nrc.gov. tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:28 Aug 22, 2013 Jkt 229001 By letter dated May 31, 2013, SHINE filed with the NRC, pursuant to Section 103 of the Atomic Energy Act and part 50 of Title 10 of the Code of Federal Regulations (10 CFR), the second and final portion of a two-part application for a construction permit for a medical radioisotope production facility in Janesville, Wisconsin (SMT–2013–023, ADAMS Accession No. ML13172A361). An exemption from certain requirements of 10 CFR 2.101(a)(5), granted by the Commission on March 20, 2013 (ADAMS Accession No. ML13072B195), in response to a letter from SHINE dated February 18, 2013 (ADAMS Accession No. ML13051A007), allowed SHINE to submit its construction permit application in two parts. Specifically, the exemption allowed SHINE to submit a portion of its application for a construction permit up to six months prior to the remainder of the application regardless of whether or not an environmental impact statement or a supplement to an environmental impact statement is prepared during the review of its application. SHINE submitted part one of its construction permit application by letter dated March 26, 2013 (ADAMS Accession No. ML13088A192). A notice of receipt and availability of part one of the construction permit application was previously published in the Federal Register on May 20, 2013 (78 FR 29390). The first part of SHINE’s construction permit application contained the following information: • The description and safety assessment of the site required by 10 CFR 50.34(a)(1) • The environmental report required by 10 CFR 50.30(f) • The filing fee information required by 10 CFR 50.30(e) and 10 CFR 170.21 • The general information required by 10 CFR 50.33 • The agreement limiting access to classified information required by 10 CFR 50.37 The NRC staff published in the Federal Register on July 1, 2013 (78 FR 39342), its determination that part one of SHINE’s construction permit application is acceptable for docketing. Part two of SHINE’s application for a construction permit contains the remainder of the preliminary safety analysis report, as required by 10 CFR 50.34(a). Subsequent Federal Register notices will address the acceptability of this second portion of the tendered construction permit application for docketing and detail provisions for public participation in the construction permit application review process. SUPPLEMENTARY INFORMATION: [FR Doc. 2013–20630 Filed 8–22–13; 8:45 am] PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 52579 Dated at Rockville, Maryland, this 16th day of August, 2013. For the Nuclear Regulatory Commission. Alexander Adams, Jr., Chief, Research and Test Reactors Licensing Branch, Division of Policy and Rulemaking, Office of Nuclear Reactor Regulation. [FR Doc. 2013–20622 Filed 8–22–13; 8:45 am] BILLING CODE 7590–01–P OFFICE OF PERSONNEL MANAGEMENT Submission for Review: Report of Withholdings and Contributions for Health Benefits, Life Insurance and Retirement (Standard Form 2812); Report of Withholdings and Contributions for Health Benefits by Enrollment Code (Standard Form 2812–A); Supplemental Semiannual Headcount Report (OPM Form 1523) U.S. Office of Personnel Management. ACTION: 30-Day notice and request for comments. AGENCY: Trust Funds Group of the Office of Chief Financial Officer, Office of Personnel Management (OPM), offers the general public and other Federal agencies the opportunity to comment on changes to existing Standard Form 2812, Standard Form 2812–A, and OPM Form 1523. As required by the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. chapter 35), as amended by the Clinger-Cohen Act (Pub. L. 104– 106), OPM is soliciting comments for this collection. The information collection was previously published in the Federal Register on June 4, 2013 (78 FR 33450) allowing for a 60-day public comment period. No comments were received for this information collection. The purpose of this notice is to allow an additional 30 days for public comments. The Office of Management and Budget is particularly interested in comments that: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of OPM, including whether the information will have practical utility; 2. Evaluate the accuracy of OPM’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the SUMMARY: E:\FR\FM\23AUN1.SGM 23AUN1

Agencies

[Federal Register Volume 78, Number 164 (Friday, August 23, 2013)]
[Notices]
[Page 52579]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-20622]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-608; NRC-2013-0053]


SHINE Medical Technologies, Inc.

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of receipt and availability.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) staff 
acknowledges receipt of the second and final part of a two-part 
application for a construction permit, submitted by SHINE Medical 
Technologies, Inc. (SHINE).

ADDRESSES: Please refer to Docket ID NRC-2013-0053 when contacting the 
NRC about the availability of information regarding this document. You 
may access publicly-available information related to this action by the 
following methods:
     Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2013-0053. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-287-
3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact 
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section 
of this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may access publicly available documents online in the NRC 
Library at https://www.nrc.gov/reading-rm/adams.html. To begin the 
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's 
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number 
for each document referenced in this document (if that document is 
available in ADAMS) is provided the first time that the document is 
referenced. The application is available in ADAMS under Accession No. 
ML13172A324.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Steven Lynch, Office of Nuclear 
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC, 
20555-0001; telephone: 301-415-1524; email: Steven.Lynch@nrc.gov.

SUPPLEMENTARY INFORMATION: By letter dated May 31, 2013, SHINE filed 
with the NRC, pursuant to Section 103 of the Atomic Energy Act and part 
50 of Title 10 of the Code of Federal Regulations (10 CFR), the second 
and final portion of a two-part application for a construction permit 
for a medical radioisotope production facility in Janesville, Wisconsin 
(SMT-2013-023, ADAMS Accession No. ML13172A361).
    An exemption from certain requirements of 10 CFR 2.101(a)(5), 
granted by the Commission on March 20, 2013 (ADAMS Accession No. 
ML13072B195), in response to a letter from SHINE dated February 18, 
2013 (ADAMS Accession No. ML13051A007), allowed SHINE to submit its 
construction permit application in two parts. Specifically, the 
exemption allowed SHINE to submit a portion of its application for a 
construction permit up to six months prior to the remainder of the 
application regardless of whether or not an environmental impact 
statement or a supplement to an environmental impact statement is 
prepared during the review of its application. SHINE submitted part one 
of its construction permit application by letter dated March 26, 2013 
(ADAMS Accession No. ML13088A192). A notice of receipt and availability 
of part one of the construction permit application was previously 
published in the Federal Register on May 20, 2013 (78 FR 29390). The 
first part of SHINE's construction permit application contained the 
following information:

 The description and safety assessment of the site required by 
10 CFR 50.34(a)(1)
 The environmental report required by 10 CFR 50.30(f)
 The filing fee information required by 10 CFR 50.30(e) and 10 
CFR 170.21
 The general information required by 10 CFR 50.33
 The agreement limiting access to classified information 
required by 10 CFR 50.37

    The NRC staff published in the Federal Register on July 1, 2013 (78 
FR 39342), its determination that part one of SHINE's construction 
permit application is acceptable for docketing.
    Part two of SHINE's application for a construction permit contains 
the remainder of the preliminary safety analysis report, as required by 
10 CFR 50.34(a).
    Subsequent Federal Register notices will address the acceptability 
of this second portion of the tendered construction permit application 
for docketing and detail provisions for public participation in the 
construction permit application review process.

    Dated at Rockville, Maryland, this 16th day of August, 2013.

    For the Nuclear Regulatory Commission.
Alexander Adams, Jr.,
Chief, Research and Test Reactors Licensing Branch, Division of Policy 
and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2013-20622 Filed 8-22-13; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.